ARTICLE | Politics & Policy
FDA announces classwide changes for opioids
September 11, 2013 12:54 AM UTC
FDA on Tuesday announced classwide labeling changes and new postmarket study requirements for extended-release and long-acting opioids. The agency said manufacturers must conduct one or more (see BioC...